Investments have supported the creation of over 6,000 jobs throughout the Commonwealth
Startup takes clinical trials to patients’ homes using digital health technologies to help bring more innovative medicines to market
Technology-enabled health care services company offers cost-effective and scalable services to reduce care provider costs and improve patient outcomes.
CIT’s GAP Venture Fund began deploying capital in mid-2005. The Fund invests in high-potential early stage technology companies accelerating their path to significant growth through active partnership and company development.
Norfolk, Virginia CEO: Michael Umscheid Company Status: Private Investment Status: Current Fund: GAP Tech Fund ARCSys provides disruptive accounting software for specialized accounting standards such as the Allowance for Credit Losses. ARCSys also provides detailed business analytics and data warehousing reporting.
Charlottesville, Virginia CEO: Joel Selzer Company Status: Active Investment Status: Current Fund: GAP Tech Fund ArcheMedX is a healthcare informatics and e-learning technology company that is transforming medical education through an agile, data-driven approach to online learning. The company’s award winning e-learning platform, the ArcheViewer, significantly improves competency and performance among healthcare professionals and currently powers hundreds of online learning activities for the nation’s leading healthcare organizations.
Reston, Virginia CEO: Navroop Mitter Company Status: Private Investment Status: Current GAP Fund: GAP Tech Fund Enterprise-level, secure messaging platform.
Blacksburg, Virginia Company Status: Private Investment Status: Current Fund: GAP BioLife Fund BioTherapeutics applies computational modeling and informatics approach to accelerate the development pf disruptive, safer, and more effective therapeutics for inflammation and diabetes
Arlington, Virginia CEO: Shavanna Miller Company Status: Private Investment Status: Current Fund: GAP Tech Fund Bloompop is a game-changer in an antiquated $9 billion flower industry still stuck in the stone age. Through unique technology platforms, Bloompop connects customers to sellers through each step of the floral buying chain in every state and city in America.
Mechanicsville, Virginia CEO: Lance Ullom Company Status: Private Investment Status: Current Fund: GAP Tech Fund Blue Triangle Technologies improves the online experience by providing retailers proprietary SaaS-based Predictive Analytics, mapping page performance to online sales, calculating the ROI at optimum page speeds, and driving up revenues in real time with our conversion boost technology.
McLean, Virginia CEO: Ed Barrientos Company Status: Private Investment Status: Current Fund: GAP Tech Fund Brazen helps organizations create better engagement through chat-based online events. The world’s leading organizations use Brazen’s software platform to interact and engage with employees, job candidates, customers, students and alumni. The company is venture-backed and headquartered in the Washington, D.C. metro area.
Vienna, Virginia CEO: Amy Nichols Company Status: Private Investment Status: Current GAP Fund: GAP Tech Fund bThere is a management, streaming and editing platform for virtual reality and 360 video. Our market consists of advertising agencies, videographers, media companies and real estate offices/companies.
Herndon, Virginia CEO: James Quigley Company Status: Private Investment Status: Current Fund: GAP Tech Fund Canvas is a cloud-based software service and mobile app platform that enables businesses to replace expensive and inefficient paper forms and processes with customizable mobile apps for smartphones and tablets, with no programming or IT required. Canvas enables businesses to collect information using mobile devices, share and learn from that information and easily integrate with existing backend systems. Canvas also offers the first mobile business application library of its kind, allowing businesses from diverse industries to find mobile apps and forms specific to their needs.
Charlottesville, Virginia CEO: Andrew Krouse Company Status: Private Investment Status: Current Fund: GAP BioLife Fund Providing patients with therapies for cancer and neurologic diseases through the development of drugs that selectively inhibit the T-type calcium channel (Cav3).